KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Assets Average (2016 - 2025)

Sarepta Therapeutics (SRPT) has 15 years of Assets Average data on record, last reported at $3.6 billion in Q3 2025.

  • For Q3 2025, Assets Average rose 2.12% year-over-year to $3.6 billion; the TTM value through Sep 2025 reached $3.6 billion, up 2.12%, while the annual FY2024 figure was $3.6 billion, 13.06% up from the prior year.
  • Assets Average reached $3.6 billion in Q3 2025 per SRPT's latest filing, roughly flat from $3.6 billion in the prior quarter.
  • Across five years, Assets Average topped out at $3.8 billion in Q4 2024 and bottomed at $2.7 billion in Q3 2021.
  • Average Assets Average over 5 years is $3.2 billion, with a median of $3.1 billion recorded in 2023.
  • The widest YoY moves for Assets Average: up 20.54% in 2021, down 5.25% in 2021.
  • A 5-year view of Assets Average shows it stood at $2.9 billion in 2021, then grew by 8.16% to $3.1 billion in 2022, then rose by 1.43% to $3.2 billion in 2023, then rose by 18.65% to $3.8 billion in 2024, then decreased by 5.15% to $3.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $3.6 billion in Q3 2025, $3.6 billion in Q2 2025, and $3.7 billion in Q1 2025.